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SUMMARY 
Purpose: FDG PET hypometabolism is important for surgical planning in patients with temporal 
lobe epilepsy (TLE), but its significance remains unclear in patients who do not have evidence of 
mesial temporal sclerosis (MTS) on MRI. We examined surgical outcomes in a group of PET-
positive, MRI-negative patients and compared them with those of patients with MTS. 
 
Methods: We queried the Thomas Jefferson University Surgical Epilepsy Database for patients 
who underwent anterior temporal lobectomy (ATL) from 1991-2009 and who had unilateral 
temporal PET hypometabolism without an epileptogenic lesion on MRI (PET+/MRI-). We 
compared this group to the group of patients who underwent ATL and who had MTS on MRI. 
Patients with discordant ictal EEG were excluded. Surgical outcomes were compared using 
percentages of Engel Class I outcomes at 2 and 5 years as well as Kaplan-Meier survival 
statistic, with time to seizure recurrence as survival time. A subgroup of PET+/MRI- patients 
who underwent surgical implantation prior to resection were compared to PET+/MRI- patients 
who went directly to resection without implantation. 
 
Key Findings: There were 46 PET+/MRI- patients (of whom 36 had 2-year surgical outcome 
available) and 147 MTS patients. There was no difference between the two groups with regard to 
history of febrile convulsions, generalized tonic-clonic seizures, interictal spikes, depression, or 
family history. Mean age at first seizure was higher in PET+/MRI- patients (19±13 vs.14±13 
years, Mann-Wittney test, p=0.008) and disease duration was shorter (14 years±10 vs. 22±13, 
student’s t test, p=0.0006) Class I surgical outcomes did not differ significantly between the 
PET+/MRI- patients and the MTS group (percentages of 2 and 5 year outcomes were 76% and 
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75% for the PET+/MRI- group, and 71% and 78% for the MTS group); neither did outcomes of 
the PET+/MRI- patients who were implanted prior to resection versus those who went directly to 
surgery (implanted patients had 71% and 67% Class I outcomes at 2 and 5 years, while 
nonimplanted patients had 77% and 78% Class I outcomes, p=0.66 and 0.28). Kaplan-Meier 
survival statistics for both comparisons were nonsignificant at five years. Dentate gyrus and hilar 
cell counts obtained from pathology for a sample of patients also did not differ between groups.  
 
Significance: PET-positive, MRI-negative TLE patients in our study had excellent surgical 
outcomes after ATL, very similar to those in patients with MTS, regardless of whether or not 
they undergo intracranial monitoring. These patients should be considered prime candidates for 
ATL, and intracranial monitoring is probably unnecessary in the absence of discordant data. 
 
Key words: nonlesional, presurgical evaluation, postoperative outcomes, 
fluorodeoxyglucose, positron emission tomography, temporal lobectomy, depth electrode, 
implantation 
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INTRODUCTION 
 
FDG-PET (fluorodeoxyglucose positron emission tomography) imaging was the first imaging 
modality found to be useful in the surgical evaluation of temporal lobe epilepsy (TLE). Magnetic 
Resonance Imaging (MRI) has now supplanted PET as the primary imaging tool used in the 
presurgical evaluation of TLE because of its high sensitivity (97%) and specificity (83%) for 
hippocampal sclerosis (HS), the most common pathological basis of TLE (Berkovic 1995). 
While it is established that mesial temporal sclerosis (MTS), the MRI correlate of HS, is the most 
reliable predictor of good surgical outcome (Bercovic 1995, Spencer 2005), only 58-72% of 
patients with TLE have MTS on MRI, with 16% of drug-resistant TLE patients demonstrating no 
MRI abnormality at all (Berkovic 1995) This leaves a sizable minority of TLE patients to be 
localized with other measures, including PET and intracranial monitoring. 
 
At many epilepsy centers, interictal PET imaging is routinely used in the presurgical evaluation 
of TLE patients, as hypometabolism on FDG-PET has been shown to correlate with good 
surgical outcome (Willmann et al 2007). This empirical finding notwithstanding, we know little 
about the etiology of PET hypometabolism in these patients.  Studies that correlate PET with 
pathology have found that the severity of cell loss in HS does not correspond to the degree of 
PET hypometabolism (Foldvary 1999, Obrien 2007). It also appears that the pattern of temporal 
PET hypometabolism does not correspond to the severity of temporal atrophy or MTS on MRI 
(Chassoux 2004), and indeed the overall pattern rather than degree of focal hypometabolism 
predicts successful surgical outcome (Dupont 2000).  Despite these differences between MRI 
and PET for presurgical evaluation, the asymmetry index for focal hypometabolism in the mesial 
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temporal lobe is higher patients who attain seizure freedom postoperatively (Delbeke 1996). PET 
hypometabolism ipsilateral to scalp EEG onset also has a high correlation with intracranial EEG 
onset, which caused Engel to conclude that those patients may go on to surgery without 
intracranial monitoring (Engel 1990). This conclusion predated the era of modern MRI scanning, 
however. 
 
Thus, the question remains whether PET positive, MRI negative patients should undergo 
intracranial EEG monitoring, or whether they may proceed directly to surgical resection if all 
other data is concordant. One case-control study matched 30 such PET positive, MRI negative 
patients who underwent standard or hippocampal-sparing resections to 30 age and gender 
matched patients with MTS on MRI, concluding that surgical outcome was equivalent between 
groups (Carne et al 2004). At our center, 28 PET positive, MRI negative cases were reviewed 
and found to have excellent surgical outcomes, although intracranially implanted patients were 
excluded (Mintzer 2004). The purpose of our study is to compare surgical outcomes in a large 
group of PET positive, MRI negative patients to those with MTS on MRI, as the latter is the 
group with most established excellent surgical outcome. We also included those who underwent 
intracranial electrode implantation, with the goal of determining whether invasive monitoring 
altered surgical outcomes in this group of patients.  
 
METHODS 
 
Approval for a retrospective study was obtained from our institutional review board. We queried 
the Thomas Jefferson Surgical Database from the Comprehensive Epilepsy Center for patients 
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who underwent standard anterior temporal lobectomy (ATL) from 1991-2009. We selected 1991 
as a cutoff point because of lesser MRI quality prior to 1991 resulting in decreased sensitivity to 
MTS. Historical data, MRI, PET, aura and seizure types, interictal and ictal EEG, history of 
depression, and follow up data were obtained from the database, which is prospectively 
maintained. The methods of presurgical evaluations at our center have been previously described 
(Sperling et al 1996, Chandrasekar et al 2007).  PET hypometabolism was defined qualitatively 
by visual inspection of a consensus of radiologists and epileptologists at surgical conference. 
 
Selection and Exclusion Criteria 
 
We divided the patients into two groups: (1) PET+/MRI-, consisting of patients who had 
temporal PET hypometabolism ipsilateral to the surgical site and an MRI without an 
epileptogenic lesion (as described below), and (2) MTS, consisting of patients who had MRI 
findings of hippocampal atrophy, with or without increased mesial temporal signal intensity. We 
also queried the database for patients with the above imaging criteria who underwent intracranial 
implants only, who did not undergo surgery, or who underwent nonstandard ATL instead.  
 
In order to limit the study to patients who were likely to have true TLE, we excluded patients 
with risk factors for multifocal epilepsy, including severe head injury with loss of consciousness, 
cerebral anoxia, central nervous system infection, or stroke. Patients with brain tumors on 
imaging or histopathology were also excluded, as the progressive nature of these conditions 
separates them from other TLE etiologies with regard to prognosis. We also excluded patients 
who had any extratemporal MRI findings that were potentially epileptogenic, including 
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hemiatrophy, stroke, encephalomalacia, or other cortical lesions. Patients who had PET 
hypometabolism in regions other than the temporal lobe, thalamus or cerebellum (as the latter 
two regions are commonly hypometabolic in TLE patients (Theodore et al 1987, Henry et al 
1993)), were excluded as well. Non-specific white matter lesions typical of migraine or mild 
microvascular disease, and generalized brain atrophy were not considered exclusion criteria. 
Finally, we excluded patients who had ictal scalp EEG findings that were extratemporal, 
posterior temporal, or contralateral to the imaging abnormality.  
 
Hippocampal Pathology 
 
Owing to the age of much of the patient cohort and limitations of the dataset, reliable 
histopathologic data for the majority of our patients could not be obtained.  
However, in addition to the information obtained from our surgical database, we were able to 
locate hilar neuron densities and dentate gyrus granule cell densities for a sample of our patients 
from 1992-1997. The methods have been previously described elsewhere (Dlugos 1999). Eight 
patients in the PET+/MRI- group and six patients from our MTS group had available data. 
 
Statistical Analysis 
 
Student’s t test or Mann-Wittney test (for nonparametric variables)  were used to compare age at 
surgery, age at disease onset, disease duration and mean hilar neuron and dentate granule cell 
densities between both groups. To compare the categorical variables, including febrile 
convulsions, a family history of epilepsy, gender, laterality, history of depression, seizure type 
Deleted: as
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and handedness, we used the Fisher’s Exact test or Chi-Squared tests as applicable. To compare 
surgical outcomes, in addition to comparing percentages of patients with Class I outcomes at 2 
and 5 years postoperatively with Fisher's Exact Test, we used Kaplan-Meier analysis with 
seizure free time as “survival time”. Statistical analysis was performed with WinSTAT software 
[version 2009.1 R. Fitch, Germany]. 
 
RESULTS 
 
A total of 193 patients met inclusion criteria and underwent standard ATL, with 46 patients 
included in the PET+/MRI- group, and 147 patients in the MTS group. Mean age at first seizure 
was higher in PET+/MRI- patients (19±13 vs.14±13 years, Mann-Wittney test, p=0.008) and 
disease duration was shorter (14 years±10 vs. 22±13, student’s t test, p=0.0006) The groups were 
not significantly different with regard to, history of febrile convulsions, presence of generalized 
tonic clonic seizures, history of depression, family history of epilepsy, handedness or surgical 
side (Table 1). 
 
The mean total years of postsurgical follow up were 5.4 for all patients (5.1 for the MTS patients 
and 6.3 for the PET+/MRI- patients). Of the PET+/MRI- patients, 36 had two or more years of 
follow up and 23 had five or more years of follow up; of the MTS patients, 115 had two or more 
and 71 had five or more years of follow up. In addition to the 193 patients who underwent 
surgical resection, an additional 33 patients (14.6%) in either group either had no surgery, 
underwent nonstandard ATL or underwent implantation without proceeding to surgical resection. 
Of the total group of 226 patients, 73% went directly to surgical resection and 12% underwent 
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implantation prior to resection. (These are summarized in Table 2.) Of the PET+/MRI- patients 
who underwent depth electrode implantation, 6/7 were performed before 1999, whereas the 
nonimplanted patients were equally split between the two decades. 
 
A summary of the presence and types of auras among the two groups is given in Table 3. The 
only noteworthy difference in aura type appeared to be the presence of cognitive auras (including 
déjà vu, forced thoughts, or other cognitive phenomena), which were found in 8/46 (17%) of 
PET+/MRI- patients and in 9/145 (6%) of MTS patients (p = 0.058). 
 
Class I surgical outcomes at 2 and 5 years were 76% and 75% for PET+/MRI- patients and 71% 
and 78% for MTS patients (p=0.68 for 2 years, 0.78 at 5 years using Fisher's Exact Test). The 
Kaplan-Meier survival curves using time to any seizure recurrence as a first event were not 
statistically different between PET+/MRI- patients and MTS patients at five years (p=0.44, see 
figure 1). In addition, the surgical outcomes between PET+/MRI- patients who underwent 
intracranial implantation prior to resection and those who did not were also similar: 
nonimplanted patients had 77% and 78% Class I outcomes at 2 and 5 years, respectively, and 
implanted patients had 71% and  67% percent Class I outcomes at 2 and 5 years (p=0.66 and 
0.28 at 2 and 5 years). The Kaplan-Meier probability statistic for implanted versus nonimplanted 
patients was nonsignificant at p=0.9 (See figure 2).   
 
Subanalyses were performed with regard to interictal EEG characteristics and with regard to 
hippocampal neuron densities. Detailed information on interictal spikes on scalp EEG recording 
was reviewed for 186 patients (Table 4). Patients were categorized into concordant, discordant 
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and null (no interictal spikes) groups. Patients with concordant interictal spikes were defined as 
having the majority of spikes (greater than 50%) seen in the ipsilateral sphenoidal, mid-temporal, 
inferior temporal or frontotemporal electrodes, with few or no extratemporal spikes. Patients who 
had interictal spikes not meeting these criteria were categorized as discordant.  The majority of 
patients had concordant spikes (84% in the PET+/MRI- group, 86% in the MTS group). Of the 
discordant spikes in either group, there was no identifiable pattern to their locations – ie, 
PET+/MRI- patients did not appear to have in excess a posterior temporal or contralateral 
discordant interictal spike focus (see Table 4). A Kaplan-Meier survival analysis using time to 
first postoperative seizure recurrence was performed for patients in the PET+/MRI- group with 
concordant and discordant interictal spikes, which revealed no difference in postoperative 
surgical outcomes in those patients who had discordant interictal spike discharges (Figure 3). For 
the histopathological analysis, PET+/MRI- patients were similar to MTS patients  in terms of 
their mean hilar neuron and dentate gyrus granule cell densities (dentate granule cell densities 
were 123,553 ± 64,494 for PET+/MRI- patients and 120,646 ± 56,776 for MTS patients, and 
hilar neuron densities were 2461± 2381 for PET+/MRI- patients and 2758±2600 for MTS 
patients, units in cells/mm3, p=NS).  
 
Further review of PET+/MRI- patients who underwent intracranial monitoring without 
subsequent resection revealed two patients who were thought to have frontal seizures prior to 
implantation; one of these was eventually determined to have seizures arising from Broca’s area, 
while the other had seizures which could not be localized on intracranial EEG. A third patient 
had anterior and posterior temporal interictal spikes on the right while ictal scalp EEG localized 
to the left; implantation revealed bitemporal seizures. Two other patients had non-localized ictal 
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scalp EEG which was not adequately localized after implantation. 
 
 In order to ensure that the survival analysis was not biases by differential dropout of 
particular groups of patients, demographic data including age of disease onset, disease duration, 
gender, handedness, laterality, family history of epilepsy and history of GTC seizures and the 
concordance of interictal spikes were compared between the patients who fell out of the survival 
analysis (ie, patients with five or fewer years of follow up who did not have a seizure recurrence) 
in the PET+/MRI- and MTS groups. No significant differences between those groups were 
found. 
 
DISCUSSION  
 
We report the outcome of a large group of PET positive, MRI negative patients, with comparison 
of surgical outcomes in these patients to those in patients with mesial temporal sclerosis on MRI. 
Furthermore, we directly compared the surgical outcomes of patients who underwent surgical 
electrode implantation prior to resection to patients who did not. The mean and median follow up 
times for our patients were at least 4 years, thus providing good long term data on surgical 
outcome for a little-studied group, and allowing for survival analysis between groups. 
 
Our study robustly showed that the PET+/MRI- group of patients have excellent postsurgical 
outcomes, with 75% categorized as Class I at 5 years. In particular, the five-year surgical 
outcomes for these patients were quite comparable to those of patients with MTS on MRI. These 
findings corroborate those found in a previous studies (Carne et al 2004, Struck et al 2011) and 
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provide further evidence that the PET+/MRI- patients are very good surgical candidates. 
  
In some centers, this group of patients generally undergoes intracranial implantation due to the 
absence of a structural abnormality. The PET+/MRI- patients in our center had a low rate of 
surgical implanation, yet still had excellent outcomes. Furthermore, those patients who were 
implanted surgically had equivalent outcomes to those who went directly to resection, with 
Kaplan-Meier survival outcomes having no significant difference at five years. Thus, it is likely 
unnecessary to undertake expensive and invasive surgical implantation for many otherwise 
uncomplicated cases of temporal lobe epilepsy with concordant PET and EEG, even when MRI 
is negative. 
 
Further review of our PET+/MRI- patients who did not undergo resection after implantation 
showed that for most, their presurgical workup had relevant pieces of discordant or ambiguous 
data that made them less than ideal candidates for resection despite their concordant PET and 
ictal EEG findings. Thus, while most PET+/MRI- TLE patients may likely proceed directly to 
resection, there are some for whom intracranial monitoring may still be appropriate. In our 
patient population, the PET+/MRI- patients who were implanted and underwent surgery were 
mostly earlier cases, which is probably a result of more conservative practices in years past. 
Since we have found that those implanted patients who otherwise fit our criteria did well, it 
appears that a less stringent approach has been appropriate. 
 
Another clinical implication from our findings is that any MRI-negative patient with TLE should 
be considered for a PET study. A recent meta-analysis showed that MRI-negative epilepsy 
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patients had a significantly lower seizure-free outcome compared to lesional cases (Téllez-
Zenteno et al 2010), but this does not preclude finding particular subgroups of MRI-negative 
epilepsy in whom surgical prognosis is better; our data suggest that PET+/MRI- patients without 
discordant data should have much higher rates of seizure freedom, likely equivalent to the 
lesional group. Among predictive factors for seizure outcome on a series of MRI negative 
patients, non-congruent PET was the strongest predictive factor for an Engel Class of III or IV 
(Immonen et al, 2010); this suggests that a PET scan may be considered to rule out candidates 
for surgery as well. 
 
Our study is limited by the retrospective design, as is the case for most surgical outcome studies. 
Carrying out a prospective study for epilepsy surgery in which individualized judgments are 
superseded by randomization is not feasible, given the complexities of individual cases. We 
attempted to minimize the biases of complex cases by limiting our data to groups of “clean” 
cases with minimal discordant data and without risk factors for multifocality.  We did include 
patients with discordant interictal spike discharges, as bitemporal spikes are commonly seen in 
TLE; but discordant interictal spikes did not correlate with worse surgical outcomes in our 
PET+/MRI- patients, nor was there a difference in distribution of interictal spikes between the 
PET+/MRI- patients and classic MTS patients. It is also worth noting that for those patients who 
did not undergo surgery — which occurred more frequently in the PET+/MRI- group — it is 
possible that there might have been similarly good postoperative outcomes had resections been 
pursued. 
 
The two other limitations to our study are the absence of neuropsychological data detailing 
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cognitive outcomes for this group and histopathological diagnoses. Raw neuropsychological data 
for many of the patients operated on during the 1990's was not available, but a further analysis is 
being performed for a subset of patients and will be reported separately. Since clinicians often 
hesitate to resect a dominant nonlesional temporal lobe because of a theoretical potential for 
verbal memory dysfunction, this data will help guide practicioners on whether or not to implant 
the dominant PET+/MRI- patient based on actual postoperative cognitive outcomes. Regarding 
histopathologic data, while diagnoses were not available for most patients, we were able to 
obtain hippocampal cell density data for a small subgroup and found no difference in 
hippocampal cell densities in the regions of the hilum and dentate gyrus between the patients 
with MTS and the patients with temporal PET hypometabolism and normal MRI. These data 
provide further evidence that the distinction between MRI+ and MRI-/PET+ patients with TLE is 
likely not a function of differences in hippocampal cell density (Foldvary 1999, Obrien 2007, 
Dlugos 2009). 
 
The underlying etiology of PET+/MRI- TLE continues to be enigmatic. Carne et al found 
differences in the history of febrile convulsions and presence of hippocampal sclerosis, and 
concluded that their patients appeared to be a surgically remediable syndrome which was distinct 
from MTS (Carne et al 2004).  The only significant clinical differences we found between these 
patients and those with MTS is that the PET+/MRI- patients developed epilepsy at a later age 
and had shorter disease durations at time of surgery, along with a trend towards more cognitive 
auras. While our results would indeed suggest that these patients are largely surgically 
remediable, their distinction as a homogeneous clinical entity is not supported by our findings. In 
fact, recent reports together have found heterogeneous causes of PET+/MRI- epilepsy such as 
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small temporal pole encephaloceles (Abou-Hamden et al 2010)  or Taylor-type focal cortical 
dysplasias (Chassoux et al 2010). Interestingly, a recent series showed that only one of three 
MRI- patients with HS had lateralized PET hypometabolism (Bien et al 2009); thus, it would 
appear that PET hypometabolism does not result from HS. In that same series, the MRI- patients 
categorized as indefinite histopathology who had lateralized PET had nonspecific irregularities 
of hippocampal architecture such as blurring of the gray-white matter junctions, gliosis or 
heterotopic neurons (Bien et al 2009, personal communication). Thus, it is possible that the 
PET+/MRI- TLE group represents a milder form of hippocampal abnormality than classic HS 
that is nonetheless equally remediable to surgical treatment. 
LoPinto-Khoury, Carla #16 
 16
ACKNOWLEDGEMENTS 
Leigh Stott, Matthew Brink  
LoPinto-Khoury, Carla #17 
 17
DISCLOSURE OF CONFLICTS OF INTEREST 
None of the authors has any conflict of interest to disclose. 
 
LoPinto-Khoury, Carla #18 
 18
ETHICAL STATEMENT  
We confirm that we have read the Journal’s position on issues involved in ethical publication and 
affirm that this report is consistent with those guidelines. 
LoPinto-Khoury, Carla #19 
 19
REFERENCES 
 
Abou-Hamden A, Lau M, Fabinyi G, Berkovic SF, Jackson GD, Mitchell LA, Kalnins R, Fitt G, 
Archer JS. (2010) Small temporal pole encephaloceles: A treatable cause of "lesion negative" 
temporal lobe epilepsy. Epilepsia. 51:2199-2202.  
Berkovic SF, McIntosh AM, Kalnins RM, Jackson GD, Fabinyi GCA, Brazenor GA, Bladin PF, 
Hopper JL. (1995) Preoperative MRI predicts outcome of temporal lobectomy: An actuarial 
analysis. Neurology. 45:1358-1363.  
Bien CG, Szinay M, Wagner J, Clusmann H, Becker AJ, Urbach H. (2009) Characteristics and 
surgical outcomes of patients with refractory magnetic resonance imaging-negative epilepsies. 
Arch Neurol. 66:1491-1499.  
Carne RP, OBrien TJ, Kilpatrick CJ, MacGregor LR, Hicks RJ, Murphy MA, Bowden SC, Kaye 
AH, Cook MJ. (2004) MRI-negative PET-positive temporal lobe epilepsy: A distinct surgically 
remediable syndrome. Brain. 127:2276-2285.  
Cascino GD, Jack Jr. CR, Parisi JE, Sharbrough FW, Hirschorn KA, Meyer FB, Marsh WR, 
O'Brien PC. (1991) Magnetic resonance imaging-based volume studies in temporal lobe 
epilepsy: Pathological correlations. Ann of Neurol. 30:31-36.  
Cendes F, Cascino GD. (2010) MRI signs of hippocampal sclerosis seen in healthy volunteers: 
What is the clinical relevance? Neurology. 74:534-535.  
LoPinto-Khoury, Carla #20 
 20
Chassoux F, Rodrigo S, Semah F, Beuvon F, Landre E, Devaux B, Turak B, Mellerio C, Meder 
JF, Roux FX, Daumas-Duport C, Merlet P, Dulac O, Chiron C. (2010) FDG-PET improves 
surgical outcome in negative MRI taylor-type focal cortical dysplasias. Neurology. 75:2168-
2175.  
Chassoux F, Semah F, Bouilleret V, Landre E, Devaux B, Turak B, Nataf F, Roux F-. (2004) 
Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: A correlative 
study. Brain. 127:164-174.  
Dlugos DJ, Jaggi J, O'Connor WM, Ding XS, Reivich M, O'Connor MJ, Sperling MR. (1999) 
Hippocampal cell density and subcortical metabolism in temporal lobe epilepsy. Epilepsia. 
40:408-413.  
Dupont S, Semah F, Clémenceau S, Adam C, Baulac M, Samson Y. (2000) Accurate prediction 
of postoperative outcome in mesial temporal lobe epilepsy: A study using positron emission 
tomography with 18fluorodeoxyglucose. Arch Neurol. 57:1331-1336.  
Engel JJ, Henry TR, Risinger MW, Mazziotta JC, Sutherling WW, Levesque MF, Phelps ME. 
(1990) Presurgical evaluation for partial epilepsy: Relative contributions of chronic depth-
electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology. 40:1670.  
LoPinto-Khoury, Carla #21 
 21
Foldvary N, Lee N, Hanson MW, Coleman RE, Hulette CM, Friedman AH, Bej MD, Radtke 
RA. (1999) Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe 
epilepsy. Epilepsia. 40:26-29.  
Foldvary N, Nashold B, Mascha E, Thompson EA, Lee N, McNamara JO, Lewis DV, Luther JS, 
Friedman AH, Radtke RA. (2000) Seizure outcome after temporal lobectomy for temporal lobe 
epilepsy: A kaplan-meier survival analysis. Neurology. 54:630-634.  
Henry TR, Babb TL, Engel Jr. J, Mazziotta JC, Phelps ME, Crandall PH. (1994) Hippocampal 
neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann of Neurol. 36:925-
927.  
Henry TR, Mazziotta JC, Engel JJ. (1993) Interictal metabolic anatomy of mesial temporal lobe 
epilepsy. Arch Neurol. 50:582-589.  
Immonen A, Jutila L, Muraja-Murro A, Mervaala E, Äikiä, M, Lamusuo, S, Kuikka, J, Vanninen 
E, Alafuzoff, I, Ikonen, A, Vanninen R, Vapalahti, M, Kälviäinen, R, (2010). Long-term epilepsy 
surgery outcomes in patients with MRI-negative temporal lobe epilepsy. Epilepsia. 51:2260-
2269. 
Labate A, Gambardella A, Aguglia U, Condino F, Ventura P, Lanza P, Quattrone A. (2010) 
Temporal lobe abnormalities on brain MRI in healthy volunteers: A prospective case-control 
study. Neurology. 74:553-557.  
LoPinto-Khoury, Carla #22 
 22
Manno EM, Sperling MR, Ding X., Jaggi J., Alavi A., O'Connor MJ, Reivich M. (1994) 
Predictors of outcome after anterior temporal lobectomy: Positron emission tomography. 
Neurology. 44:2321.  
O'Brien TJ, Newton MR, Cook MJ, Berlangieri SU, Kilpatrick C, Morris K, Berkovic SF. (1997) 
Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe 
epilepsy. Epilepsia. 38:74-80.  
Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Shinnar S, Langfitt JT, Walczak 
TS, Pacia SV, for The Multicenter Study of Epilepsy Surgery. (2005) Predicting long-term 
seizure outcome after resective epilepsy surgery: The multicenter study. Neurology. 65:912-918.  
Sperling MR, O'Connor MJ, Saykin AJ, Plummer C. (1996) Temporal lobectomy for refractory 
epilepsy. JAMA. 276:470-475.  
Struck AF, Hall LT, Floberg JM, Perlman SB, Dulli DA.(2011), Surgical decision making in 
temporal lobe epilepsy: A comparison of [18F]FDG-PET, MRI, and EEG. Epilepsy Behav. 22: 
293-297. 
Tellez-Zenteno JF, Hernandez Ronquillo L, Moien-Afshari F, Wiebe S. (2010) Surgical 
outcomes in lesional and non-lesional epilepsy: A systematic review and meta-analysis. Epilepsy 
Res. 89:310-318.  
Formatted: Font: Italic
LoPinto-Khoury, Carla #23 
 23
Vielhaber S, Von Oertzen JH, Kudin AF, Schoenfeld A, Menzel C, Biersack H, Kral T, Elger 
CE, Kunz WS. (2003) Correlation of hippocampal glucose oxidation capacity and interictal 
FDG-PET in temporal lobe epilepsy. Epilepsia. 44:193-199.  
Wiebe S, Blume WT, Girvin JP, Eliasziw M. (2001) A randomized, controlled trial of surgery 
for temporal-lobe epilepsy. N Engl J Med. 345:311-318.  
 
Willmann O, Wennberg R, May T, Woermann FG, Pohlmann-Eden B. (2007) The contribution 
of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe 
epilepsy. A meta-analysis. Seizure. 16:509-520.  
 
LoPinto-Khoury, Carla #24 
 24
 
FIGURE LEGENDS 
 
Figure 1. Kaplan-Meier survival plot of probability of postoperative seizure freedom in 
PET+/MRI- patients versus MTS patients, with survival as time to first seizure recurrence. No 
statistically significant difference was seen. 
 
Figure 2. Probability of postoperative seizure freedom in PET+/MRI- patients who underwent 
surgical EEG electrode implantation prior to resection versus those who went directly to surgical 
resection. There was no difference in surgical outcomes. 
 
Figure 3. Probability of postoperative seizure freedom in PET+/MRI- patients with concordant 
versus discordant interictal spike discharges. There was no difference in surgical outcomes 
between the two groups. 
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TABLES 
 
Table 1. Summary of Demographic Data 
  PET+/MRI- MTS  
  percent  number percent number  p value 
Total number of subjects   46   147   
      
Age of onset (mean in years)   19   14 0.008 
      
Age at surgery  34  36 0.567 
      
Disease Duration  14  22 0.0006 
      
History of GTC seizures 52% 24 65% 97 0.091 
      
Gender         
Men 41% 19 44% 65 0.865 
Women 59% 27 56% 82   
         
Seizure lateralization         
Right 43% 20 53% 78 0.311 
Left 57% 26 47% 69   
         
Handedness         
Right 85% 39 85% 125 0.888 
Left 15% 7 13% 19   
Ambidextrous 0% 0 1% 2   
Nonresponders   0   1   
         
Family history of Epilepsy         
Positive 24% 11 91% 42 0.699 
Negative 63% 29 63% 92   
Unknown   6   13   
          
History of Febrile 
Convulsions         
Positive 30% 14 44% 64 0.167 
Negative 65% 30 56% 84   
Nonresponders   2   1   
      
History of Depression 35% 16 32% 47 0.72 
      
Number of subjects who 
underwent intracranial 
monitoring 15% 7 14% 21 0.815 
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Table 2. Patients fulfilling study criteria who did not undergo standard resection or only 
underwent surgical EEG electrode implantation. 
 PET+/MRI- percent MTS percent 
Direct to surgery 39 67% 126 75% 
Intracranial monitoring proceeding to standard ATL 7 12% 21 12% 
no surgery 5 9% 5 3% 
modified ATL  2 3% 11 7% 
Intracranial monitoring without proceeding to 
resection 5 9% 5 3% 
total 58  168  
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Table 3. Auras in PET+/MRI- patients and MTS patients 
  
PET+/MRI- 
n=46 
MTS 
n=145 p value 
% without auras 21.7% 29.0% 0.337 
% with auras 78.3% 71.0%   
type:       
cognitive, déjà vu or forced 
thought auras 17.4% 6.2% 0.058 
epigastric/thoracic 17.4% 21.4% 0.41 
nausea 10.9% 11.0% 0.612 
"indescribable feeling" 15.2% 7.6% 0.243 
other 17.4% 24.9%   
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Table 4. Interictal Spike Data  
 PET+/MRI-  MTS 
Number with concordant interictal spikes 37  122 
Number with discordant interictal spikes 4  14 
discordant contralateral temporal 1  4 
discordant ipsilateral anterior 2  2 
discordant ipsilateral posterior 1  3 
discordant contralateral extratemporal 0  1 
bitemporal 0  2 
discordant hemispheric  0  2 
Null (no interictal spikes) 3  6 
 Totals 44  142 
 
